Prostate Cancer

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

By

A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

By

Prehabilitation before initiating ADT in older men with prostate cancer may improve functioning, even in men on short-term ADT.

Better Understanding of Prostate Cancer Genetic Test Results Needed

Better Understanding of Prostate Cancer Genetic Test Results Needed

By

Some men who undergo multigene testing for inherited prostate cancer misinterpret findings of variants of uncertain significance.

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

By

Addition of abiraterone to androgen deprivation therapy for patients with hormone-naïve advanced prostate cancer may be a new standard of care.

Continued Enzalutamide Strategy Fails to Benefit mCRPC

Continued Enzalutamide Strategy Fails to Benefit mCRPC

By

Men who had PSA progression on enzalutamide but continued on the drug did not have improved PFS when abiraterone was added to their therapy.

Testosterone and Prostate Cancer Treatment

Testosterone and Prostate Cancer Treatment

Testosterone may offer an inexpensive alternative to other prostate cancer therapies, new research indicates.

Drinking Coffee Might Reduce Risk of Developing Prostate Cancer

Drinking Coffee Might Reduce Risk of Developing Prostate Cancer

By

Men who drank 3 or more cups of Italian style coffee per day had a lower risk of developing prostate cancer.

Mitochondrial Bioenergetics Profile Indicates Likelihood of Radiation-Induced Fatigue in Prostate Cancer

Mitochondrial Bioenergetics Profile Indicates Likelihood of Radiation-Induced Fatigue in Prostate Cancer

By

Mitochondrial oxidative phosphorylation rate in lymphocytes of patients with nonmetastatic prostate cancer appears to be associated with fatigue.

Multimodal Strategy Shows Promise in Metastatic Prostate Cancer

Multimodal Strategy Shows Promise in Metastatic Prostate Cancer

By

New paradigm of hormone therapy, surgery, and radiation therapy was shown effective at achieving undetectable disease in patients with metastatic prostate cancer.

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

By

Patients who practiced Eischens yoga twice a week had less fatigue, sexual dysfunction, and certain scores related to quality of life.

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

By

Several clinical societies came together to create appropriate use criteria for the use of bone scintigraphy in patients with prostate and breast cancer.

PSA Screening Rates Level Off in United States

PSA Screening Rates Level Off in United States

Decline in prostate-specific antigen (PSA) screening followed U.S. Preventive Services Task Force recommendations.

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

By

Family history does not predict aggressiveness of prostate cancer or suitability for active surveillance as a treatment option.

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

By

Abiraterone acetate and prednisone reduced PSA levels in a small group of clinical trial participants with metastatic prostate cancer who did not initially respond to ADT.

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

patients with prostate cancer who attended yoga classes had less fatigue and better sexual and urinary function.

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

By

Steroid produced by human fetal liver reduces testosterone levels, holding potential as treatment for advanced prostate cancer.

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

By

Conversations about benefits and drawbacks of PSA testing improved after the USPSTF updated its recommendations on PSA testing; however, some disparities in quality of these discussions increased.

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

By

Immunotherapy alone is not effective in prostate cancer; however, combining it with PD-1/PD-L1 and VISTA inhibitors is effective.

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

By

ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

By

Virtual Environment Radiotherapy (VERT) program eases anxiety and improves understanding of radiation therapy for patients with prostate cancer.

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

By

QoL after radical prostatectomy, EBRT, or brachytherapy vs active surveillance for prostate cancer are similar.

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

By

Interactive app helps patients with prostate cancer manage their treatment-related symptoms.

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

By

Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

By

F-18-fluciclovine PET helps detect and localize recurrent prostate cancer allowing for individualized, targeted therapy.

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

By

A single 19-Gy fraction of brachytherapy was found as effective as a longer regimen of low-dose-rate brachytherapy in localized prostate cancer.

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

By

Cabozantinib activated innate immunity and completely eradicated prostate cancer in a study using a mouse model.

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

By

Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.

No Association Between Vasectomy and Prostate Cancer Risk

No Association Between Vasectomy and Prostate Cancer Risk

By

There is no association between vasectomy and the risk of overall, high-grade, or advanced-stage prostate cancer or prostate cancer-related mortality.

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

By

A lower dose of abiraterone acetate with a low fat meal may have the same effect as taking the standard dose as recommended on an empty stomach.

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

By

Treatment expectations of individuals with metastatic prostate cancer and their health care providers often do not match.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs